Honokiol, widely known as an antitumor agent, has been used as an antiangiogenesis drug lead. In this paper, 47 honokiol analogues and derivatives were investigated for their antiangiogenic activity by application of the transgenic zebrafish screening model, antiproliferative and cytotoxic activity against HUVECs, and three tumor cell lines by MTT assay. 3',5-Diallyl-2,4'-dihydroxy-[1,1'-biphen-yl]-3,5'-dicarbaldehyde (8c) was found to suppress the newly grown segmental vessels from the dorsal aorta of zebrafish and prevent inappropriate vascularization as well as exhibit more potent inhibitory effects on the proliferation of HUVECs, A549, HepG2, and LL/2 cells (IC(50) = 15.1, 30.2, 10.7, and 21.7 μM, respectively) than honokiol (IC(50) = 52.6, 35.0, 16.5, and 65.4 μM, respectively). Analogue 8c also effectively inhibited the migration and capillary-like tube formation of HUVECs in vitro. The antiangiogenic effect and antiproliferative activity of these structurally modified honokiol analogues and derivatives have led to the establishment of a structure-activity relationship.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/jm200830u | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Neolignan Honokiol and Its Synthetic Derivative Honokiol Hexafluoro Reduce Neuroinflammation and Cellular Senescence in Microglia Cells.
Cells
October 2024
Department of Neurosciences, Psychology, Drug Research and Child Health (Neurofarba), University of Floence, Viale G. Pieraccini 6, 50121 Florence, Italy.
Article Synopsis
- Microglia, the immune cells in the brain, contribute to neuroinflammation and aging, both of which increase the risk of neurodegenerative disorders like Alzheimer's disease (AD).
- This study examines the effects of Honokiol (HNK), a natural compound, and its synthetic version, Honokiol Hexafluoro (CH), on reducing inflammation and cellular aging in microglia cells.
- Results show that both HNK and CH effectively reduce harmful inflammation, improve anti-inflammatory responses, and inhibit markers of cellular senescence, suggesting their potential as therapeutic agents in treating age-related neurodegenerative diseases.
Identification of Honokiol-Based Scaffold to Design Tankyrase 1/2 Inhibitors by In Silico and In Vitro Studies.
Chem Biodivers
October 2024
Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084, Fisciano (SA), Italy.
Recently, we identified magnolol bioinspired derivatives as new Tankyrase 1/2 (TNKS1/2) inhibitors by our Inverse Virtual Screening protocol. Based on these findings, in the present contribution, we enlarged our investigation of neolignans to the natural product honokiol (1) and a group of its analogues (2-8). By integrating in silico analysis and Surface Plasmon Resonance experiments, we investigated the binding of tested compounds against biological target under investigations.
View Article and Find Full Text PDFNovel Pesticide Candidates Inspired by Natural Neolignan: Preparation and Insecticidal Investigation of Honokiol Analogs Containing 2-Aminobenzoxazole-Fused Core Scaffold.
J Agric Food Chem
September 2024
Shanxi Key Laboratory of Integrated Pest Management in Agriculture, College of Plant Protection, Shanxi Agricultural University, Taigu, 030801 Shanxi Province, P. R. China.
Article Synopsis
- Researchers developed new insecticides based on the natural compound honokiol, creating novel versions with a specific chemical structure (2-aminobenzoxazole) that were tested against two major agricultural pests.
- The new compounds showed much stronger larvicidal and antifeedant effects than honokiol itself and traditional botanical insecticides.
- Additionally, these compounds demonstrated good effectiveness in greenhouse tests and exhibited moderate toxicity to non-target mammalian cells, indicating potential for safe use in agriculture.*
Honokiol hexafluoro confers reversal of neuropathological markers of HIV infection in a murine SCID model.
Neurotherapeutics
March 2024
Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA; Atlanta VA Medical Center, Decatur, GA, USA. Electronic address:
Cognitive impairment remains a persistent challenge in people living with HIV (PWLH) despite antiretroviral therapy (ART) due to ART's inability to eliminate brain HIV. HIV-induced cognitive dysfunction results from immune dysregulation, ongoing neuroinflammation, and the continuous virus presence, collectively contributing to cognitive deficits. Therefore, adjunctive therapies are needed to reduce cerebral HIV reservoirs, mitigate neuroinflammation, and impede cognitive dysfunction progression.
View Article and Find Full Text PDFHonokiol targeting ankyrin repeat domain of TRPV4 ameliorates endothelial permeability in mice inflammatory bowel disease induced by DSS.
J Ethnopharmacol
May 2024
Collaborative Innovation Center of Research on Functional Ingredients from Agricultural Residues, Guangxi Key Laboratory of Efficacy Study on Chinese Materia Medica and China-ASEAN Joint Laboratory for International Cooperation in Traditional Medicine Research, Guangxi University of Chinese Medicine, Nanning, China. Electronic address:
Ethnopharmacological Relevance: As a classic traditional Chinese medicine, Magnolia officinalis (M. officinalis) is widely used in digestive diseases. It has rich gastrointestinal activity including inflammatory bowel disease (IBD) treatment, but the mechanism is not clear.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!